Kestrel Therapeutics
Allston
About Kestrel Therapeutics
Kestrel Therapeutics is a medical research and devenlopment company that offers treatment solutions for RAS cancers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $40.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2021)
- Website: kestreltherapeutics.com
- Phone: +1 617 460-3772
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/kestrel-therapeutics-79486 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.